DBV Technologies SA/ FR0010417345 /
2024-05-21 5:37:04 PM | Chg. -0.020 | Volume | Bid3:01:15 AM | Ask3:01:15 AM | High | Low |
---|---|---|---|---|---|---|
1.300EUR | -1.52% | 96,450 Turnover: 126,899.062 |
1.284Bid Size: 5 | 1.320Ask Size: 500 | 1.370 | 1.284 |
GlobeNewswire
05-07
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire
04-04
Information regarding the total number of voting rights and total number of shares of the Company a...
GlobeNewswire
03-08
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Docu...
GlobeNewswire
03-04
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
GlobeNewswire
2023-12-04
Information regarding the total number of voting rights and total number of shares of the Company a...
GlobeNewswire
2023-11-09
DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE T...
GlobeNewswire
2023-11-06
Monthly information regarding the total number of voting rights and total number of shares of the C...
GlobeNewswire
2023-10-31
DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety...
GlobeNewswire
2023-10-27
DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
GlobeNewswire
2023-10-16
DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
GlobeNewswire
2023-10-05
Monthly information regarding the total number of voting rights and total number of shares of the C...
GlobeNewswire
2022-03-14
DBV Technologies to Present at the Oppenheimerâs 32nd Annual Healthcare Conference